Haemonetics Corporation (HAE)
Health Care ยท Surgical & Medical Instruments & Apparatus
Haemonetics Corporation (HAE) is listed on the New York Stock Exchange, where its shares have traded since May 9, 1991. SentiSense covers Haemonetics Corporation in the Health Care sector, and its Standard Industrial Classification is Surgical & Medical Instruments & Apparatus. Chris Simon is its chief executive officer. The company reports 3,009 employees, and its corporate website is www.haemonetics.com.
About Haemonetics Corporation
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.
Latest reported results
Haemonetics reported revenue of $357.8 million for Q2 FY2027, up 9.3% from the same period a year earlier.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 317 institutions reported holding HAE, with 49.6 million shares worth $3.7 billion in aggregate. The largest reported holders were BlackRock, Vanguard and Neuberger Berman Group.
More on HAE
- HAE sentiment: whether news and social coverage of Haemonetics Corporation leans bullish or bearish, and the stories driving it.
- HAE ownership: all 317 reporting institutions, plus insider and congressional trades.
- HAE financials: revenue, net income, operating margin and free cash flow through Q2 FY2027.
Frequently asked questions
What does Haemonetics Corporation do?
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces.
What sector is HAE in?
SentiSense classifies Haemonetics Corporation in the Health Care sector, and its Standard Industrial Classification is Surgical & Medical Instruments & Apparatus.
Where does HAE stock trade?
Haemonetics Corporation (HAE) is listed on the New York Stock Exchange, where its shares have traded since May 9, 1991.
Who is the CEO of Haemonetics Corporation?
Chris Simon is the chief executive officer of Haemonetics Corporation.